Search
for

    Sort by

    Research 481–510 of 1000+

    1. Treatment of refractory hematospermia with Finasteride: A prospective placebo-controlled study Bangladesh journal of urology · 2023
    2. Clinical effectiveness of finasteride versus hydroxychloroquine in the treatment of frontal fibrosing alopecia: A randomized controlled trial Journal of Cosmetic Dermatology · 2023
    3. Topical Finasteride: A Comprehensive Review of Androgenetic Alopecia Management for Men and Women Cureus · 2023
    4. Trazodone and chlorpromazine a proposal treatment for syndrome post-finasteride and syndrome of post-selective serotonin reuptake inhibitors (post-SSRI) Zenodo (CERN European Organization for Nuclear Research) · 2023
    5. Development and evaluation of finasteride niosomes targeting to hair follicles for the management of androgenic alopecia Journal of Drug Delivery Science and Technology · 2023
    6. UTILIZAÇÃO DE FINASTERIDA NO TRATAMENTO DA HIPERPLASIA PROSTÁTICA BENIGNA – RELATO DE CASO Enciclopédia Biosfera · 2023
    7. Finasteride nano-transferosomal gel formula for management of androgenetic alopecia: ex vivo investigational approach DOAJ (DOAJ: Directory of Open Access Journals) · 2018
    8. Finasteride와 저용량 Dutasteride 병용요법으로 호전된 안드로겐성 탈모증 1예 대한피부과학회지 · 2017
    9. Finasteride: Facts and Myths Global journal of dermatology & venereology · 2015
    10. Pharmacokinetics of two different formulations of finasteride (topical and oral) in male volunteers with androgeneic alopecia 2013
    11. Why would men use finasteride in 2005? Current Prostate Reports · 2005
    12. Long-Term Effectiveness of Finasteride for BPH Journal watch · 2004
    13. Efficacy and Tolerability of a Topical Gel Containing Mimicking Growth Factors Oligopeptides, Caffeine, Taurine and an Iron-Chelating Complex in Subjects with Androgenetic Alopecia Treated with Topical Minoxidil or Oral Finasteride: a Prospective, 6-Month, Randomized, Assessor-Blinded, 4-Arm, Parallel Group Study Clinical and experimental dermatology and therapies · 2022
    14. Topical finasteride dose evaluation for treatment of androgenetic alopecia using computer simulations Annales pharmaceutiques françaises · 2021
    15. The potential involvement of cholinergic system in finasteride induced cognitive dysfunction Psychoneuroendocrinology · 2020
    16. Commentary on article on clinical efficacy of oral finasteride by Won, Lew, and Sim Dermatologic Therapy · 2018
    17. Bernstein’s Consent and Information on Finasteride and Propecia® Hair transplant forum international · 2016
    18. Finasteride: Facts and Myths Global journal of dermatology & venereology · 2015
    19. Finasteride in androgenetic alopecia in men 2007
    20. Finasteride treatment of premature androgenetic alopecia 9th European Congress of Endocrinology · 2007
    21. Male Androgenetic Alopecia : Response To Finasteride Indian Journal of Dermatology · 2004
    22. [Therapy of androgenetic alopecia with finasteride. What must be considered in consultation and drug prescribing]. PubMed · 1999
    23. Assessing the quality of life and health outcomes of Androgenic Alopecia patients using Propecia 2016
    24. Persistent Gynecomastia due to Short-term Low-dose Finasteride for Androgenetic Alopecia JCEM case reports · 2024
    25. Clinical Case Notes. Propecia-associated bilateral cataract Clinical and Experimental Ophthalmology · 2004 · 11 citations
    26. Finasteride-related Leydig cell tumour: report of a case and literature review Andrologia · 2011 · 5 citations
    27. 저용량 Finasteride(1mg/일, Propeciaⓡ)투여 후 악화된 일측성의 원발성 여성형 유방 1예 2004
    28. How to Deal with the Issues of Fertility, Malignancies, and the Postfinasteride Syndrome while Prescribing Finasteride for Male Pattern Hair Loss Skin appendage disorders · 2022
    29. Response to Article “Depression Circumstantially Related to the Administration of Finasteride for Androgenetic Alopecia” (J Dermatol, 29, 665-669, 2002) Journal of Dermatology · 2003
    30. P.6.028 Transnosography of impulsiveness:A comparison among different psychiatric disorders European Neuropsychopharmacology · 2004